Non-Hodgkin Lymphoma Treatment at the University of Colorado Cancer Center
Being diagnosed with non-Hodgkin lymphoma can be a scary experience.
At the University of Colorado Cancer Center, you can rely on a knowledgeable team of experts who will walk with you every step of the way. Armed with the latest in research and technology, you’ll travel new ground in the fight against cancer.
As the Rocky Mountain region’s only National Cancer Institute-designated Comprehensive Cancer Center, we specialize in the care and treatment of non-Hodgkin lymphoma. Treatment, care and support are tailored to each individual patient.
And the same expert team of doctors, nurses and specialists walk alongside you throughout your entire journey.
Our dedication to a cure for cancer is unwavering. That’s why our 5-year survival rates are up to 30% higher than state, regional and national averages.
To begin your journey with a committed and caring team of lymphoma experts, call us today at (720) 848-0300.
What is Non-Hodgkin Lymphoma?
Lymphomas are cancers of the immune system. They result when a lymphocyte (a type of white blood cell that helps the body fight infections) undergoes a malignant change, and then multiplies.
These cells crowd out healthy cells, and create tumors that may show up in the lymph nodes and other parts of the immune system like the skin.
- Non-Hodgkin lymphomas occur at any age, and are often marked by enlarged lymph nodes, fever and weight loss.
- Lymphomas can be “aggressive” (fast-growing) or “indolent” (slow-growing). They can be formed from either B-cells or T-cells.
Regardless of what type of lymphoma you or a loved one may be facing, the University of Colorado Cancer Center has a caring team of experts ready to help in the fight.
Non-Hodgkin Lymphona at a Glance
- Approximately 474,880 people are living with non-Hodgkin lymphoma or are in remission.
- An estimated 65,000 new cases of non-Hodgkin lymphoma are diagnosed in the United States each year.
- More than 95% of non-Hodgkin lymphoma cases occur in adults over 60 years of age. Men have a slightly higher risk than women.
Source: The Leukemia and Lymphoma Society